Director, Infection Control
Dr. Blodget's clinical interests include HIV, transplant infections and infectious disease. Her research interests include the incidence and outcomes of vancomycin-resistant enterococcus (VRE) infection in patients with cirrhosis who are awaiting liver transplantation. She is conducting a large ongoing retrospective study in these patients to determine the risk factors as well as morbidity and mortality of VRE infection.
Dr. Blodget earned her Master's in Epidemiology and Biostatistics from Boston University and then received her medical degree from University College Cork in Cork Ireland. She then went on to complete her fellowship in Infectious Diseases at LAC+USC Medical Center.
Cryptococcal disease in the solid organ transplant setting: review of clinical aspects with a discussion of asymptomatic cryptococcal antigenemia. Curr Opin Organ Transplant. 2017 Aug; 22(4):307-313. View in: PubMed
. View in: PubMed
Reactivation of Chagas disease in a bone marrow transplant patient: case report and review of screening and management. Transpl Infect Dis. 2013 Dec; 15(6):E264-7. View in: PubMed
Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients. Transpl Infect Dis. 2012 Jun; 14(3):305-10. View in: PubMed
Relationship between microbial translocation and endothelial function in HIV infected patients. PLoS One. 2012; 7(8):e42624. View in: PubMed
Preanalytical variables affecting the quantification of fatty acid ethyl esters in plasma and serum samples. Clin Chem. 1999 Dec; 45(12):2183-90. View in: PubMed
The hydrolysis of fatty acid ethyl esters in low-density lipoproteins by red blood cells, white blood cells and platelets. Alcohol. 1999 Oct; 19(2):163-8. View in: PubMed